Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2016
17th World Conference on Lung Cancer
Access to all presentations that occur during the 17th World Conference on Lung Cancer in Vienna, Austria
Presentation Date(s):- Dec 4 - 7, 2016
- Total Presentations: 2466
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
Presentations will be available 24 hours after their live presentation time
-
+
JCES01 - Joint IASLC - Chinese Society for Clinical Oncology - Chinese Alliance Against Lung Cancer Session
- Type: Joint Chinese / English Session
- Track:
- Presentations: 28
- Moderators:F.R. Hirsch
- Coordinates: 12/04/2016, 08:00 - 11:45, Stolz 1
-
+
JCES01.01 - Breakfast and Informal Networking
08:00 - 08:20
- Abstract
No abstract available for this presentation
-
+
JCES01.02 - Welcome and Introduction
08:20 - 08:30 | Author(s): F.R. Hirsch
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Discovering the East: Precision Medicine in China
08:30 - 08:30
- Abstract
No abstract available for this presentation
-
+
JCES01.04 - Liquid Biopsy in Monitoring Dynamic Changes of Driver Genes in Advanced NSCLC
08:30 - 08:50 | Author(s): Q. Zhou
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
JCES01.05 - New Clinical Trials on Gene Alteration in China
08:50 - 09:10 | Author(s): S. Lu
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Precision Medicine – Perspectives from the West
09:10 - 09:10
- Abstract
No abstract available for this presentation
-
+
JCES01.06 - European Perspective Phase I Strategy
09:10 - 09:30 | Author(s): C. Rolfo
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
JCES01.07 - North American Perspective
09:30 - 09:50 | Author(s): P.A. Bunn, Jr.
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
JCES01.08 - Break
09:50 - 10:10
- Abstract
No abstract available for this presentation
-
+
Abstract Presentations from China Related to Precision Medicine
10:10 - 10:10
- Abstract
No abstract available for this presentation
-
+
JCES01.09 - A Comparison of ddPCR and ARMS for Detecting EGFR T790M Status from Advanced NSCLC Patients with Acquired EGFR-TKI Resistance
10:10 - 10:20 | Author(s): W. Wang
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
JCES01.10 - Serial Quantitative Assessment of Plasma Circulating Tumor DNA by Digital NGS in Patients with Lung Cancer
10:20 - 10:30 | Author(s): Y. Zhao
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
JCES01.11 - Altered Expression of Programmed Death-Ligand 1 after Neo-Adjuvant Chemotherapy in Patients with Lung Squamous Cell Carcinoma
10:30 - 10:40 | Author(s): Z. Song
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
JCES01.12 - Discussant Oral Abstracts
10:40 - 10:55 | Author(s): J.C. Yang
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
JCES01.13 - Discussant Posters
10:55 - 11:10 | Author(s): X. Zhang
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
JCES01.14 - Mutational Profiling of Non-Small-Cell Lung Cancer Patients Resistant to First-Generation EGFR Tyrosine Kinase Inhibitors Using next Generation Sequencing
11:10 - 11:10 | Author(s): Y. Jin
- Abstract
Loading... -
+
JCES01.15 - Analysis of Genomic Alterations and Heterogeneity in Pulmonary Adenoid Cystic Carcinoma by Next-Generation Sequencing
11:10 - 11:10 | Author(s): M. Li
- Abstract
Loading... -
+
JCES01.16 - A MET Inhibitor in the Treatment of Metastatic Non Small Cell Lung Cancer with MET Amplification
11:10 - 11:10 | Author(s): T. Zhang
- Abstract
Loading... -
+
JCES01.17 - A Phase I Dose Expansion Study of Epitinib to Evaluate Efficacy and Safety in EGFR Mutation Positive (EGFRm+) NSCLC Patients with Brain Metastasis
11:10 - 11:10 | Author(s): Q. Zhou
- Abstract
Loading... -
+
JCES01.18 - Dual Positive PD-L1 and CD8+ TIL Represents a Predominant Subtype in NSCLC and Correlates with Augmented Immunogenicity
11:10 - 11:10 | Author(s): S. Liu
- Abstract
Loading... -
+
JCES01.19 - Clinicopathologic Characteristics, Genetic Variability and Therapeutic Options of RET Rearrangement Patients in Lung Adenocarcinoma
11:10 - 11:10 | Author(s): Z. Song
- Abstract
Loading... -
+
JCES01.20 - Patients with ROS1 Rearrangement Positive Non-Small Cell Lung Cancer Benefit from Pemetrexed-Based Chemotherapy
11:10 - 11:10 | Author(s): Z. Song
- Abstract
Loading... -
+
JCES01.21 - Molecular Profiling and Survival of Primary Pulmonary Neuroendocrine Carcinoma with Completely Resection
11:10 - 11:10 | Author(s): G. Lou
- Abstract
Loading... -
+
JCES01.22 - Comparison of Four Leading Technologies for Detecting EGFR Mutations in Circulating Tumor DNA from Patients with Non-Small Cell Lung Carcinoma
11:10 - 11:10 | Author(s): X. Kang
- Abstract
Loading... -
+
JCES01.23 - EGFR Mutation Status Analysis in Cerebrospinal Fluid and Plasma of Advanced Lung Adenocarcinoma with Brain Metastases
11:10 - 11:10 | Author(s): L. Shi
- Abstract
Loading... -
+
JCES01.24 - Molecular Mechanism of Transformation from Adenocarcinoma to Small-Cell Lung Cancer after EGFR-TKI
11:10 - 11:10 | Author(s): J. Han
- Abstract
Loading... -
+
JCES01.25 - Closing Remarks
11:10 - 11:25
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
JCES01.03 - Perspectives on Precision Medicine for Early Stage NSCLC
11:25 - 11:45 | Author(s): J. Hu
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
PL02a - Distinguished Lecture
- Type: Plenary
- Track:
- Presentations: 1
- Moderators:R. Pirker
- Coordinates: 12/05/2016, 08:45 - 09:00, Hall D (Plenary Hall)
-
+
Welcome Address
08:45 - 09:00 | Author(s): H. Fischer
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P1.05 - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Early Stage NSCLC
- Presentations: 79
- Coordinates: 12/05/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P1.05-001 - Creation and Early Validation of Prognostic miRNA Signatures for Squamous Cell Lung Carcinoma by the SPECS Lung Consortium
14:30 - 14:30 | Author(s): D. Harpole
- Abstract
Loading... -
+
P1.05-027 - Novel Prognostic Gene Expression Signatures for Squamous Cell Lung Carcinoma: A Study by the SPECS Lung Consortium
14:30 - 14:30 | Author(s): R. Bueno
- Abstract
Loading...
-
+
IASLC Business Meeting
- Type: Networking Opportunity
- Track:
- Presentations: 2
- Coordinates: 12/06/2016, 14:30 - 15:00, Schubert 2
-
+
WCLC 2016 Business Meeting Awards
14:30 - 14:50 | Author(s): F.R. Hirsch
- Abstract
No abstract available for this presentation
-
+
Travel Award Winners
14:50 - 15:00 | Author(s): F.R. Hirsch
- Abstract
No abstract available for this presentation
-
+
P2.03b - Poster Session with Presenters Present
- Type: Poster Presenters Present
- Track: Advanced NSCLC
- Presentations: 98
- Coordinates: 12/06/2016, 14:30 - 15:45, Hall B (Poster Area)
-
+
P2.03b-035 - EGFR FISH as Potential Predictor of Necitumumab Benefit with Chemotherapy in Squamous NSCLC: Subgroup Analyses from SQUIRE
14:30 - 14:30 | Author(s): C. Genova
- Abstract
Loading... -
+
P2.03b-048 - Access to Biomarker Testing in Patients with Advanced Non-Small Cell Lung Cancer
14:30 - 14:30 | Author(s): A.K. Ganti
- Abstract
Loading... -
+
P2.03b-053 - Role of KRAS Mutation Status in NSCLC Patients Treated on SWOG S0819, a Phase III Trial of Chemotherapy with or without Cetuximab
14:30 - 14:30 | Author(s): P. Mack
- Abstract
Loading...
-
+
SC21 - Predictive Biomarkers for Outcome of Systemic Therapy in NSCLC
- Type: Science Session
- Track: Biology/Pathology
- Presentations: 5
- Moderators:K. Kerr
- Coordinates: 12/06/2016, 16:00 - 17:30, Hall C7
-
+
SC21.03 - Predictive Biomarkers for Immune Checkpoint Inhibitors in Lung Cancer
16:40 - 17:00 | Author(s): F.R. Hirsch
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
PL04b - Plenary Keynote Lecture
- Type: Plenary
- Track:
- Presentations: 1
- Moderators:F.R. Hirsch
- Coordinates: 12/07/2016, 09:45 - 10:15, Hall D (Plenary Hall)
-
+
PL04b.01 - The Role of Doctors in a Globalized World
09:45 - 10:15
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
OA19 - Translational Research in Early Stage NSCLC
- Type: Oral Session
- Track: Early Stage NSCLC
- Presentations: 8
- Moderators:G. Heller
- Coordinates: 12/07/2016, 11:00 - 12:30, Schubert 3
-
+
OA19.01 - A Standardized and Validation of Prognostic Gene Expression Signatures for Squamous Cell Lung Carcinoma by the SPECS Lung Consortium
11:00 - 11:10 | Author(s): W.G. Richards
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MA15 - Immunotherapy Prediction
- Type: Mini Oral Session
- Track: Chemotherapy/Targeted Therapy/Immunotherapy
- Presentations: 12
- Moderators:O. Arrieta
- Coordinates: 12/07/2016, 14:20 - 15:50, Schubert 1
-
+
MA15.03 - The Predictive Value of Mutation/Neoantigen Burden from ctDNA on the Efficacy of PD-1 Blockade in Advanced NSCLC
14:32 - 14:38 | Author(s): W. Cai
- Abstract
Loading... -
+
MA15.11 - Acquired Resistance Mechanisms to EGFR Kinase Inhibitors Alter PD-L1 Expression Status in Lung Cancer
15:32 - 15:38 | Author(s): K. Suda
- Abstract
Loading...
-
+
MA16 - Novel Strategies in Targeted Therapy
- Type: Mini Oral Session
- Track: Chemotherapy/Targeted Therapy/Immunotherapy
- Presentations: 12
- Moderators:G. Purkalne
- Coordinates: 12/07/2016, 14:20 - 15:50, Strauss 2
-
+
MA16.10 - Lung-MAP (S1400) Lung Master Protocol: Accrual and Genomic Screening Updates
15:20 - 15:26 | Author(s): V. Papadimitrakopoulou
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.